IDNA iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| IDNA | -2.9% | +13.8% | +53.7% | +56.8% | +28.8% | -2.6% |
| Equity average (4725 funds) | -2.4% | +1.6% | +2814.7% | +65092.7% | +14.6% | +1.5% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$38K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA MODERNA | 14.62% |
| 2 | GMAB.CO GENMAB | 5.98% |
| 3 | TWST TWIST BIOSCIENCE | 4.94% |
| 4 | REGN REGENERON PHARMACEUTICALS | 4.21% |
| 5 | BAYN.DE BAYER AG | 4.21% |
| 6 | 4502.T TAKEDA PHARMACEUTICAL | 3.78% |
| 7 | EXEL EXELIXIS INC | 3.74% |
| 8 | VRTX VERTEX PHARMACEUTICALS | 3.42% |
| 9 | MRK MERCK & CO INC | 3.40% |
| 10 | RVMD REVOLUTION MEDICINES | 3.38% |
| 11 | INCY INCYTE CORP | 3.33% |
| 12 | ROP.SW ROCHE PS PAR AG | 3.27% |
| 13 | SAN.PA SANOFI SA | 2.98% |
| 14 | IPN.PA IPSEN SA | 2.84% |
| 15 | BNTX BIONTECH SE ADR | 2.78% |
| 16 | IOVA IOVANCE BIOTHERAPEUTICS INC | 2.75% |
| 17 | GSK.L GLAXOSMITHKLINE | 2.70% |
| 18 | CAI CARIS LIFE SCIENCES | 2.63% |
| 19 | ABCL ABCELLERA BIOLOGICS | 2.45% |
| 20 | IDYA IDEAYA BIOSCIENCES | 2.38% |
| 21 | IBRX IMMUNITYBIO | 2.20% |
| 22 | VIR VIR BIOTECHNOLOGY | 1.54% |
| 23 | 4528.T ONO PHARMACEUTICAL | 1.50% |
| 24 | RCUS ARCUS BIOSCIENCES | 1.38% |
| 25 | NVAX NOVAVAX | 1.37% |
| 26 | CRSP CRISPR THERAPEUTICS AG | 1.15% |
| 27 | NUVB NUVATION BIO CLASS A | 0.93% |
| 28 | PSNL PERSONALIS | 0.86% |
| 29 | XNCR XENCOR | 0.78% |
| 30 | RIGL RIGEL PHARMACEUTICALS | 0.70% |
| 31 | 6887.HK SUNSHINE LAKE PHARMA LTD CLASS H | 0.69% |
| 32 | VSTM VERASTEM INC | 0.65% |
| 33 | CRVS CORVUS PHARMACEUTICALS | 0.63% |
| 34 | JANX JANUX THERAPEUTICS | 0.62% |
| 35 | KURA KURA ONCOLOGY | 0.58% |
| 36 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA | 0.52% |
| 37 | 2595.HK GENFLEET THERAPEUTICS (SHANGHAI) I | 0.51% |
| 38 | ALVO ALVOTECH SA | 0.49% |
| 39 | NTLA INTELLIA THERAPEUTICS | 0.42% |
| 40 | DNA GINKGO BIOWORKS HOLDINGS CLASS A | 0.42% |
| 41 | VLA.PA VALNEVA | 0.42% |
| 42 | DSGN DESIGN THERAPEUTICS | 0.36% |
| 43 | 2696.HK SHANGHAI HENLIUS BIOTECH H | 0.35% |
| 44 | CTMX CYTOMX THERAPEUTICS | 0.32% |
| 45 | OCGN OCUGEN | 0.28% |
| 46 | 174900.KQ ABCLON INC | 0.24% |
| 47 | PRME PRIME MEDICINE | 0.11% |
| 48 | IDNA BLK CSH FND TREASURY SL AGENCY | 0.11% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Jun 15, 2026 | $0.1254 |
| Dec 16, 2025 | $0.1555 |
| Jun 16, 2025 | $0.1529 |
| Dec 17, 2024 | $0.1110 |
| Jun 11, 2024 | $0.1114 |
| Dec 20, 2023 | $0.1693 |
| Jun 7, 2023 | $0.0708 |
| Jun 9, 2022 | $0.1359 |
| Dec 13, 2021 | $0.2564 |
| Jun 10, 2021 | $0.0521 |
| Dec 14, 2020 | $0.0362 |
| Jun 15, 2020 | $0.0837 |
| Dec 16, 2019 | $0.2402 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in IDNA in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error